Roberts P B
Br J Cancer. 1979 Jun;39(6):755-60. doi: 10.1038/bjc.1979.129.
Procarbazine has been shown to be a hypoxic cell sensitizer of moderate ability in E. coli B/r, with an achievable enhancement ratio of 1.4 at subtoxic concentrations. The drug appears to act in a manner similar to the expected with the electron-affinic radiosensitizers. However, procarbazine and the electron-affinic sensitizers differ in two important respects. Unlike the electron-affinic sensitizers, procarbazine is not easily reduced, but is easily oxidized. It is more toxic to aerobic than to hypoxic cells. At the drug dosages in present clinical use, procarbazine is likely to be only a weak radiosensitizer. The possible implications of the data for the further development of a new class of sensitizers and combination therapy are discussed.
丙卡巴肼已被证明是大肠杆菌B/r中一种具有中等能力的乏氧细胞增敏剂,在亚毒性浓度下可实现的增强比为1.4。该药物的作用方式似乎与预期的亲电子放射增敏剂相似。然而,丙卡巴肼和亲电子增敏剂在两个重要方面存在差异。与亲电子增敏剂不同,丙卡巴肼不易被还原,但容易被氧化。它对需氧细胞的毒性比对乏氧细胞的毒性更大。在目前临床使用的药物剂量下,丙卡巴肼可能只是一种弱放射增敏剂。本文讨论了这些数据对新型增敏剂的进一步开发和联合治疗的可能意义。